OncoPharm cover image

NAPOLI 3, POUT, & Ivosidenib - Azole DDIs

OncoPharm

00:00

NAPOLI‑3 statistical assumptions and power

John explains the study's assumptions, sample size (≈750–770), hazard ratio target, and power calculations.

Play episode from 04:13
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app